EC
JAZZ icon

Estate Counselors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Estate Counselors’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-6,120
Closed -$975K – 152
2022
Q4 		$975K Buy
6,120
+45
+0.7% +$6.59K 0.14% 106
2022
Q3 		$809K Buy
+6,075
New +$924K 0.13% 98

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.22B AUM 26.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Estate Counselors's JAZZ Position: Q1 2023 in Review

Estate Counselors sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2023, closing a stake of 6,120 shares — an estimated $975K sold.

Estate Counselors first reported a position in JAZZ in Q3 2022 and held it in 2 quarters. The position peaked at $975K in Q4 2022. 471 funds tracked by Wall St. Rank hold JAZZ as of Q1 2023.

  • Estate Counselors reported no remaining Jazz Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • Estate Counselors sold 6,120 Jazz Pharmaceuticals shares in Q1 2023, an estimated $975K.
  • Estate Counselors first reported a position in Jazz Pharmaceuticals in Q3 2022 and held it in 2 quarters.
  • Estate Counselors's Jazz Pharmaceuticals position peaked at $975K in Q4 2022.
  • 471 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2023.

Based on Estate Counselors's 13F filing for Q1 2023, filed 4 May 2023.